Compare Rockwell Automation (ROK) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rockwell Automation vs 10X Genomics Inc — how do they compare? Rockwell Automation trades at $466.2 (market cap $51.04B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Rockwell Automation is far larger — about 9.3× 10X Genomics Inc's market cap, and Rockwell Automation pays a 1.2% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| ROK | TXG | |
|---|---|---|
Market Cap | $51.04B | $5.48B |
Sector | Industrials | Health |
52-Week High | $495.08 | $45.80 |
52-Week Low | $328.67 | $11.34 |
Enterprise Value | $54.67B | $5.02B |
Dividend Yield | 1.2% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
